Envision Pharma Group, a leading global technology-enabled scientific communications company, has promoted Paul Archer to Chief Commercial Strategy Officer.
To drive continual revenue growth through service synergies and the implementation of new services, Archer, in his new role, will oversee the development of an integrated commercial group strategy. The new position reflects Envision’s continued expansion and goals to transform the pharmaceutical industry, ultimately leading to life-changing outcomes and being the global medical affairs partner of preference.
“Envision Pharma Group has promoted Paul Archer to Chief Commercial Strategy Officer. “
Archer said: “I am thrilled to be taking on this role. Envision is full of purpose-driven, talented people who thrive on delivering impactful, often award-winning work for our clients and their patients. I am genuinely excited to be able to apply my twenty years of strategic and commercial experience to drive a successful integrated commercial group for Envision and to realize the opportunities and value this creates for our clients, patients, talent, and Envision as a whole.”
CEO, Envision Pharma Group, David Thompson, stated: “Paul has been a strong addition to Envision since he joined a year ago, and he will now lead a growing mandate as Chief Commercial Strategy Officer as we continue to exploit synergies across our four verticals of scientific services, technology, emerging biotech, and value, as well as uncover new service offerings through investment and acquisition that can help us improve our partnership strength with clients.”